EFFECT OF SEMAGLUTIDE ON PHYSICAL FUNCTION, BODY COMPOSITION, AND BIOMARKERS OF AGING IN OLDER ADULTS

Abstract

Insulin resistance and obesity are associated with sarcopenia and functional decline, but these important outcomes are not usually considered when choosing medications for diabetes or body weight management. Semaglutide is a GLP1 receptor agonist that typically results in average reductions in hemoglobin A1c of 1.